Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Circulation 116 , 188195 (2007)
Following treatment with varying concentrations of BPC 157 and 24 hours of incubation, the cells were administered 0.1 ug/mL of growth hormone and incubated for an additional 24 hours in order to accurately measure cell viability by MTT assay
Product quality verification remains essential for safety
Community research plans now often model subcutaneous amounts, but no approved clinical protocol or published human pharmacokinetic study has established those subcutaneous amounts
Compound Comparison Feature Class BPC-157 15-amino-acid synthetic pentadecapeptide TB-500 Synthetic 17-amino-acid Thymosin Beta-4 fragment Feature Common research focus BPC-157 Tendon, gut, vessel models
Hereto, A
